Valuation : Burning Rock Biotech Limited

Market Cap 709M 105M 90.78M 85.12M 77.7M 146M 10.07B 147M 1.01B 394M 5.08B 396M 387M 16.85B P/E 2024
-1.46x
P/E 2025 -27.1x
Enterprise Value 271M 40.3M 34.73M 32.56M 29.73M 56M 3.85B 56.18M 386M 151M 1.94B 151M 148M 6.45B EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
61.34%
Yield 2024 *
-
Yield 2025 -
1 day+2.00%
1 week+4.29%
Current month+14.61%
1 month+10.99%
3 months+0.99%
6 months-60.22%
Current year-49.38%
1 week 9.11
Extreme 9.108
10.9
1 month 8.7
Extreme 8.7
11.27
Current year 6.79
Extreme 6.79
41.72
1 year 6.79
Extreme 6.79
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
213.65
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 01/01/2014
Chief Executive Officer 48 01/01/2014
Director of Finance/CFO - 27/09/2024
Director TitleAgeSince
Chairman 48 -
Director/Board Member 55 01/06/2014
Director/Board Member 63 01/08/2016
Date Insider Type Main position Quantity % Market Cap.
31/3/26 Buy

Chief Executive Officer

314,870 0.3584%
18/3/26
Northern Light Venture Capital Development Ltd.
OtherCompany 11,880,245 13.5213%
17/3/26 Other

Director

22,718 0.0259%
Change 5-day change 1-year change 3-year change Capi.($)
-0.80%+4.29%+23.04%-21.54% 105M
-3.05%-1.41%+94.99%+489.71% 48.82B
-0.12%-0.29%+21.82%+58.01% 27.29B
-0.30%-6.27%-16.71%-37.14% 7.14B
-0.13%-2.20%+4.65%+136.63% 5.93B
-0.27%+2.21%+16.74%+75.19% 3.39B
-3.39%-1.31%-33.39%+1,912.30% 2.66B
-3.06%+6.15%+150.00%+30.52% 2.39B
+0.21%+0.21%+28.22%+24.80% 1.97B
-1.93%-10.86%-15.60%-55.00% 1.93B
Average -1.00%+2.43%+27.38%+261.35% 10.16B
Weighted average by Cap. -1.71%+2.32%+54.08%+308.90%

Financials

2024 2025
Net sales 516M 76.67M 66.06M 61.94M 56.54M 107M 7.33B 107M 735M 287M 3.7B 288M 282M 12.26B 540M 80.2M 69.11M 64.79M 59.15M 111M 7.66B 112M 769M 300M 3.87B 301M 295M 12.83B
Net income -347M -51.52M -44.39M -41.62M -38M -71.58M -4.92B -71.81M -494M -193M -2.49B -193M -189M -8.24B -55.35M -8.23M -7.09M -6.65M -6.07M -11.43M -786M -11.47M -78.85M -30.76M -397M -30.88M -30.21M -1.32B
Net Debt -474M -70.4M -60.66M -56.88M -51.92M -97.81M -6.73B -98.12M -675M -263M -3.4B -264M -259M -11.26B -438M -65.05M -56.05M -52.56M -47.98M -90.38M -6.22B -90.67M -624M -243M -3.14B -244M -239M -10.41B
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
-
Date Price Change Volume
29/08/26 USD 10.20 +2.00% 19,680
27/08/26 USD 10.00 -4.21% 6,341
26/08/26 USD 10.44 +6.53% 3,570
25/08/26 USD 9.800 -5.04% 12,844
24/08/26 USD 10.32 +5.52% 1,510